Last reviewed · How we verify

S) Ixiaro booster to MBJEV primed

Helsinki University Central Hospital · Phase 3 active Biologic

S) Ixiaro booster to MBJEV primed is a vaccine Biologic drug developed by Helsinki University Central Hospital. It is currently in Phase 3 development for Prevention of Japanese encephalitis. Also known as: Ixiaro.

Ixiaro is a vaccine that protects against Japanese encephalitis.

Ixiaro is a vaccine that protects against Japanese encephalitis. Used for Prevention of Japanese encephalitis.

At a glance

Generic nameS) Ixiaro booster to MBJEV primed
Also known asIxiaro
SponsorHelsinki University Central Hospital
Drug classvaccine
ModalityBiologic
Therapeutic areaInfectious Diseases
PhasePhase 3

Mechanism of action

It works by stimulating the body's immune system to produce antibodies against the Japanese encephalitis virus. This provides long-term immunity against the disease.

Approved indications

Common side effects

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about S) Ixiaro booster to MBJEV primed

What is S) Ixiaro booster to MBJEV primed?

S) Ixiaro booster to MBJEV primed is a vaccine drug developed by Helsinki University Central Hospital, indicated for Prevention of Japanese encephalitis.

How does S) Ixiaro booster to MBJEV primed work?

Ixiaro is a vaccine that protects against Japanese encephalitis.

What is S) Ixiaro booster to MBJEV primed used for?

S) Ixiaro booster to MBJEV primed is indicated for Prevention of Japanese encephalitis.

Who makes S) Ixiaro booster to MBJEV primed?

S) Ixiaro booster to MBJEV primed is developed by Helsinki University Central Hospital (see full Helsinki University Central Hospital pipeline at /company/helsinki-university-central-hospital).

Is S) Ixiaro booster to MBJEV primed also known as anything else?

S) Ixiaro booster to MBJEV primed is also known as Ixiaro.

What drug class is S) Ixiaro booster to MBJEV primed in?

S) Ixiaro booster to MBJEV primed belongs to the vaccine class. See all vaccine drugs at /class/vaccine.

What development phase is S) Ixiaro booster to MBJEV primed in?

S) Ixiaro booster to MBJEV primed is in Phase 3.

What are the side effects of S) Ixiaro booster to MBJEV primed?

Common side effects of S) Ixiaro booster to MBJEV primed include Injection site pain, Fatigue, Headache.

Related